Pathway Medical enables rapid evidence-based decisions at the point-of-care
Medical knowledge startup Pathway Medical announced it has raised $1.6 million in an oversubscribed funding round to expand its evidence-based clinical decision support platform. Investors include Panache Ventures, Amplify Capital, Desjardins Venture Capital, BoxOne Ventures and Formentera Capital. The company also revealed that it has released an enterprise version of its point-of-care technology. The Pathway mobile app, which is currently available directly to healthcare professionals on the Apple App Store, uses natural language processing and machine learning to provide evidence-based answers to clinical questions for the diagnosis and treatment of patients. Android and web versions of the app are planned for release.
The funding round also included participation from veteran healthcare entrepreneurs Dr. Josh Landy (ICU physician and co-founderof Figure 1), Cherif Habib (CEO of Dialogue, TSE: CARE), and emergency physician entrepreneurs Dr. Julien Martel, Dr. Louis Charbonneau and Dr. Alexandre Tratch, co-founders of DXA, an AI-powered medical triage startup that was acquired by Dialogue in 2018.
“We are thankful for all of our investors and partners, and for their continued support in our efforts to democratize medical knowledge and advance evidence-based care,” stated Pathway Medical co-founder and CEO Jonathan Hershon Saint-Jean. “This investment will help us scale our operations and expand the functionality of our platform to support additional use cases. Most notably, we are expanding our platform to help hospitals disseminate their own guidelines and pathways more efficiently.”
When Pathway Medical first launched, the goal of the company was to develop a knowledge base to help healthcare professionals diagnose and treat patients based on the best clinical data available. Since then, the platform has evolved into an AI-powered, evidence-based knowledge base and point-of-care medical diagnosis and treatment decision-making solution. Pathway’s mobile app enables healthcare professionals to instantly access hundreds of point-of-care guideline summaries, key findings from landmark trials, clinical calculators, drug information and more.
“The complexity of providing evidence-based care is increasing along with the accelerating pace of information generation and consensus development in the medical community,” stated Pathway Medical co-founder and Chief Medical Officer Dr. Louis Mullie. “Clinical tools that were built from the digitization of the medical textbook are ill-equipped to keep physicians informed and up-to-date. This contributes to the fact that physicians have the highest rate of burnout, depression and suicide of any profession. Healthcare professionals love Pathway because we understand their needs, and reduce cognitive load by delivering concise, quality medical guidance in an efficient, easy manner.”
The primary pain point for healthcare professionals wanting to make evidence-based decisions is information overload and clunky software that isn’t transparent or user-friendly. Pathway solves this problem with interactive pathways that help guide healthcare professionals step-by-step through evidence-based diagnostic approaches and treatment. Featuring 33 medical specialties, more than 1000 guidelines and over 25,000 graded recommendations, Pathway Medical offers one of the most robust structured knowledge bases available in a single solution. By seamlessly integrating into a healthcare professional’s daily workflow, and by harnessing the power of machine learning technology, Pathway increases the speed of delivering reliable evidence-based care.
“Amplify Capital is excited to add Pathway to our portfolio. Pathway is another perfect example of an impact investment that solves for rapid democratization of access to quality health care to populations that need it most. Pathway’s machine learning platform offers a unique proprietary decision-based product that can improve health outcomes quickly and at scale. Jonathan and his team are poised to grow the Company rapidly and we’re excited to support them to achieve their growth goals.” — Kathryn Wortsman, Managing Partner, Amplify Capital
Typically, Pathway cuts down the time it takes for a healthcare professional to make an evidence-based decision from minutes to seconds. With a net promoter score of 69, Pathway has a very enthusiastic user base of clinicians in over 180 countries and across 33 medical specialties relying on the app for efficient decision making.
“Pathway fills an unmet need for clinicians to have easy and user-friendly access to clinical guideline recommendations,” said Dr. Jonathan Afilalo, Cardiologist and Associate Professor of Medicine at McGill University. “The status quo alternative, which is clearly suboptimal, involves jumping through hoops to find guidelines and distill their essential message.”
Co-founders Jonathan Hershon Saint-Jean, Dr. Louis Mullie and Christophe Marois came up with the idea for Pathway Medical while Dr. Mullie was completing his residency in Internal Medicine and Critical Care. The trio had been developing medical software together for hospitals over the last 5 years. The goal was to develop a better way to deliver evidence-based clinical guidance than through manual research methods, 100+ page papers, and traditional, inefficient software.
For more information about Pathway Medical and its innovative medicaldecision-making platform, please visit pathway.md.